+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fibromyalgia Drug"

Fibromyalgia Treatment Global Market Report 2024 - Product Thumbnail Image

Fibromyalgia Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
From
Fibromyalgia - Pipeline Insight, 2024 - Product Thumbnail Image

Fibromyalgia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Fibromyalgia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Fibromyalgia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
US Fibromyalgia Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Fibromyalgia Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
From
From
Fibromyalgia - Competitive Landscape in 2021 - Product Thumbnail Image

Fibromyalgia - Competitive Landscape in 2021

  • Report
  • June 2021
  • 45 Pages
  • Global
From
Loading Indicator

The Fibromyalgia Drug market is a subset of the Immune Disorders Drugs market, which includes treatments for a variety of conditions related to the immune system. Fibromyalgia is a chronic disorder characterized by widespread musculoskeletal pain, fatigue, and tenderness in localized areas. Fibromyalgia drugs are used to reduce pain, improve sleep, and reduce fatigue. Commonly prescribed drugs include antidepressants, anticonvulsants, and muscle relaxants. Other treatments include physical therapy, cognitive behavioral therapy, and lifestyle modifications. The Fibromyalgia Drug market is highly competitive, with a number of companies offering treatments. Some of the major players in the market include Pfizer, Eli Lilly, Merck, and Novartis. Other companies include AbbVie, Allergan, and Teva Pharmaceuticals. Show Less Read more